Neurofibromatosis Type 2 (NF2) Latest Advances

Safety Lessons for YAP/TAZ-TEAD Inhibition: From Mechanism to Translation.

Journal: Cold Spring Harbor perspectives in biology

Published: September 04, 2026

Cardiac schwannoma in neurofibromatosis type 2 - a very rare cause of an interatrial septal mass.

Journal: Kardiologia polska

Published: August 14, 2026

Impact of rurality on inpatient outcomes in neurofibromatosis: A National Inpatient Sample study.

Journal: Clinical neurology and neurosurgery

Published: July 07, 2026

Surgical management of sporadic and schwannomatosis-associated dumbbell cervical schwannomas.

Journal: Neuro-Chirurgie

Published: July 07, 2026

Auditory Outcomes After Simultaneous Translabyrinthine Vestibular Schwannoma Resection and Cochlear Implantation: A Prospective Case Series.

Journal: Acta oto-laryngologica

Published: July 01, 2026

Development and Initial Validation of the Quality of life Evaluation in NF2-related Schwannomatosis Trials (QUEST) Assessment.

Journal: medRxiv : the preprint server for health sciences

Published: June 29, 2026

Erratum: Neurofibromatosis 2 alleviates ferroptosis and fibrosis in the aortas of spontaneously hypertensive rats through the Yes-associated protein pathway.

Journal: Journal of hypertension

Published: June 23, 2026

Clinical and Imaging Phenotype of Schwannomatosis in Children, Adolescents and Young Adults.

Journal: Cancers

Published: June 18, 2026

Repurposing anti-retroviral drugs to treat NF2-related tumours: a protocol for a phase 0 trial (RETREAT).

Journal: BMJ open

Published: June 16, 2026

Intramedullary Spinal Cord Tumors Associated with the Neurofibromatoses.

Journal: Neurosurgery clinics of North America

Published: June 09, 2026

Rapid Spontaneous Malignant Transformation of a Radiation-Naïve Vestibular Schwannoma.

Journal: The Journal of craniofacial surgery

Published: May 24, 2026

Cumulative Incidence of Epilepsy in Neurofibromatosis Type 2: A Propensity Matched Retrospective Study Using TriNetX.

Journal: Journal of the American Academy of Dermatology

Published: May 18, 2026

Neurofibromatosis Type 2 (NF2) Latest Advances

Find the Latest Research About Neurofibromatosis Type 2 (NF2)

Safety Lessons for YAP/TAZ-TEAD Inhibition: From Mechanism to Translation.

Safety Lessons for YAP/TAZ-TEAD Inhibition: From Mechanism to Translation.

Cardiac schwannoma in neurofibromatosis type 2 - a very rare cause of an interatrial septal mass.

Cardiac schwannoma in neurofibromatosis type 2 - a very rare cause of an interatrial septal mass.

Impact of rurality on inpatient outcomes in neurofibromatosis: A National Inpatient Sample study.

Impact of rurality on inpatient outcomes in neurofibromatosis: A National Inpatient Sample study.

Surgical management of sporadic and schwannomatosis-associated dumbbell cervical schwannomas.

Surgical management of sporadic and schwannomatosis-associated dumbbell cervical schwannomas.

Auditory Outcomes After Simultaneous Translabyrinthine Vestibular Schwannoma Resection and Cochlear Implantation: A Prospective Case Series.

Auditory Outcomes After Simultaneous Translabyrinthine Vestibular Schwannoma Resection and Cochlear Implantation: A Prospective Case Series.

Development and Initial Validation of the Quality of life Evaluation in NF2-related Schwannomatosis Trials (QUEST) Assessment.

Development and Initial Validation of the Quality of life Evaluation in NF2-related Schwannomatosis Trials (QUEST) Assessment.

Erratum: Neurofibromatosis 2 alleviates ferroptosis and fibrosis in the aortas of spontaneously hypertensive rats through the Yes-associated protein pathway.

Erratum: Neurofibromatosis 2 alleviates ferroptosis and fibrosis in the aortas of spontaneously hypertensive rats through the Yes-associated protein pathway.

Clinical and Imaging Phenotype of Schwannomatosis in Children, Adolescents and Young Adults.

Clinical and Imaging Phenotype of Schwannomatosis in Children, Adolescents and Young Adults.

Repurposing anti-retroviral drugs to treat NF2-related tumours: a protocol for a phase 0 trial (RETREAT).

Repurposing anti-retroviral drugs to treat NF2-related tumours: a protocol for a phase 0 trial (RETREAT).

Intramedullary Spinal Cord Tumors Associated with the Neurofibromatoses.

Intramedullary Spinal Cord Tumors Associated with the Neurofibromatoses.

Rapid Spontaneous Malignant Transformation of a Radiation-Naïve Vestibular Schwannoma.

Rapid Spontaneous Malignant Transformation of a Radiation-Naïve Vestibular Schwannoma.

Cumulative Incidence of Epilepsy in Neurofibromatosis Type 2: A Propensity Matched Retrospective Study Using TriNetX.

Cumulative Incidence of Epilepsy in Neurofibromatosis Type 2: A Propensity Matched Retrospective Study Using TriNetX.